We are live on ! Find out more
BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

Back to rankings

48 hedge funds and large institutions have $4.21M invested in Biotech Acquisition Company Warrant in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

8% less funds holding

Funds holding: 52 → 48 (-4)

17% less capital invested

Capital invested by funds: $5.06M → $4.21M (-$846K)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
4
Closed
9
Calls
$5.72M
Puts
–
Net Calls
+$5.72M
Net Calls Change
-$26K

Top Buyers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
+$254K
2
RA
Ramius Advisors
New York
+$117K
3
PAMP
Polar Asset Management Partners
Ontario, Canada
+$87.8K
4
SCM
Shaolin Capital Management
Florida
+$20.7K
5
BFM
Boothbay Fund Management
New York
+$11.9K

Top Sellers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
-$94.8K
2
Citadel Advisors
Citadel Advisors
Florida
-$87.9K
3
SRCM
Sage Rock Capital Management
New York
-$69K
4
MF
Magnetar Financial
Illinois
-$49K
5
PC
Periscope Capital
Ontario, Canada
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
26
CVI Holdings
Delaware
$4K – – –
RCM
27
Rivernorth Capital Management
Florida
$4K – – –
Walleye Trading
28
Walleye Trading
New York
$4K – – –
CS
29
Clear Street
New York
$4K +$6.29K +30,428 +192%
Citadel Advisors
30
Citadel Advisors
Florida
$3K -$87.9K -425,310 -85%
CCA
31
Castle Creek Arbitrage
Colorado
$3K – – –
PFM
32
Privium Fund Management
Netherlands
$3K – – –
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$3K – – –
WAM
34
Wolverine Asset Management
Illinois
$3K +$106 +514 +1%
SSA
35
Schonfeld Strategic Advisors
New York
$3K +$6.2K +30,000 New
AA
36
AQR Arbitrage
Connecticut
$2K – – –
UBS Group
37
UBS Group
Switzerland
$2K +$4.99K +24,160 +973%
MC
38
Meteora Capital
Florida
$2K +$5.17K +25,000 New
HF
39
HRT Financial
New York
$2K +$9.27K +44,877 +204%
AA
40
Ancora Advisors
Ohio
$1K – – –
Bank of America
41
Bank of America
North Carolina
$1K – – –
BCM
42
Basso Capital Management
Connecticut
$1K – – –
BCM
43
BCK Capital Management
Connecticut
$1K – – –
OAC
44
OMERS Administration Corp
Ontario, Canada
$1K – – –
OCAM
45
Owl Creek Asset Management
New York
$1K – – –
CC
46
Centiva Capital
New York
$1K +$3.4K +16,483 New
SCM
47
Segantii Capital Management
Hong Kong
$248 -$5.17K -25,000 -50%
SRCM
48
Sage Rock Capital Management
New York
– -$69K -286,900 Closed
MF
49
Magnetar Financial
Illinois
– -$49K -209,396 Closed
PC
50
Periscope Capital
Ontario, Canada
– -$40K -165,200 Closed
1
2
3

BIOTW Hedge Fund Activity: Q2 2022 in Review

48 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Warrant (BIOTW) for Q2 2022, worth a combined $4.21M — down 17% from $5.06M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BIOTW and 5 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 10 added.

The largest buyer was HGC Investment Management, adding an estimated $254K. The largest seller was Aristeia Capital, cutting an estimated $94.8K.

  • 48 institutional investors held Biotech Acquisition Company Warrant (BIOTW) as of Q2 2022, down from 52 in Q1 2022.
  • Funds reported $4.21M of Biotech Acquisition Company Warrant stock for Q2 2022, down 17% quarter-over-quarter.
  • 5 funds opened new Biotech Acquisition Company Warrant positions in Q2 2022 and 9 closed out, a net change of -4 holders.
  • The largest Biotech Acquisition Company Warrant buyer in Q2 2022 was HGC Investment Management, an estimated $254K added.
  • The largest Biotech Acquisition Company Warrant seller in Q2 2022 was Aristeia Capital, an estimated $94.8K sold.

Based on aggregated 13F filings for Q2 2022.